To include your compound in the COVID-19 Resource Center, submit it here.

C-Cure: Phase III data

Top-line data from the double-blind, European and Israeli Phase III CHART-1 trial in 271 evaluable patients with advanced, symptomatic CHF showed

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE